• Explore /
  • Poster
  • / Treatment patterns and outcomes for metastatic castration-resistant prostate cancer (mCRPC) in a real-world setting: A retrospective study of greater than 2500 patients.

Treatment patterns and outcomes for metastatic castration-resistant prostate cancer (mCRPC) in a real-world setting: A retrospective study of greater than 2500 patients.

Abstract Poster

Authors

Celestia Higano

Celestia S. Higano

University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA

Celestia S. Higano , Cora N. Sternberg , Fred Saad , Bertrand F. TOMBAL , Kurt Miller , Jan Kalinovsky , XiaoLong Jiao , Krishna Tangirala , A. Oliver Sartor

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 256)

DOI

10.1200/JCO.2019.37.7_suppl.256

Abstract #

256

Poster Bd #

L13

Abstract Disclosures

Similar Posters

First Author: Shingo Hatakeyama

First Author: Stephen J. Freedland

Poster

2022 ASCO Genitourinary Cancers Symposium

Real-world treatment patterns among patients with metastatic castration-resistant prostate cancer (mCRPC) in the US.

Real-world treatment patterns among patients with metastatic castration-resistant prostate cancer (mCRPC) in the US.

First Author: Elisabetta Malangone-Monaco

First Author: William K. Oh